ClinicalTrials.govpublic full text
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors
non small cell lung cancer, influenza vaccine
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 180214
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.